Quellios is a wellness company that uses patent-pending bio-optical technology to help users track and manage food-triggered inflammation through smartphone-based nutritional analysis and fingertip scans.
Quellios is a wellness technology company that has developed a platform designed to make inflammation visible and actionable through a smartphone-based solution. The company’s core technology, Snap & Sense, utilizes nutrition AI and bio-optical machine vision to allow users to track their physiological responses to food. By having users snap a photo of a meal and perform a short fingertip scan with their smartphone camera, the system analyzes nutritional composition and detects inflammation-related microvascular patterns. This approach aims to help users identify personal food triggers, uncover patterns in their digestive wellness, and receive adaptive dietary guidance without the need for traditional blood tests or lab visits.
Founded in 2025 and headquartered in Raleigh, North Carolina, Quellios focuses on empowering individuals to manage chronic inflammation and improve their long-term healthspan. The company targets consumers interested in digestive health, longevity, and human performance, addressing the challenge that food responses vary significantly between individuals. By providing personalized insights into how daily dietary choices impact the body, the platform assists users in staying ahead of discomfort and making informed wellness decisions. Quellios has engaged in research, including field studies to correlate optical signals with known inflammatory indicators, and continues to advance its technology through collaborative initiatives and funding support.